Average Insider

Where insiders trade, we follow

$KTTA
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Healthcare
Sector
Biotechnology
Industry
Tiago Reis Marques
CEO
4
Employees
$0.69
Current Price
$5.94M
Market Cap
52W Low$0.28
Current$0.6911.7% above low, 88.3% below high
52W High$3.79

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys00---
Sells00--
2 monthsBuys00---
Sells00--
3 monthsBuys00---
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
No transactions in the last 3 months. Sign up free to see 12 months of history.

Upcoming Earnings

Scheduled earnings reports
May 13, 2026
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
May 21, 2026
EPS
Estimated-$0.45
ActualN/A
Revenue
Estimated$100.00K
ActualN/A
Jun 3, 2026
EPS
Estimated-$3.40
ActualN/A
Revenue
Estimated$300.00K
ActualN/A

Past Earnings

Historical earnings results
Mar 30, 2026
EPS
Estimated-$0.18
Actual-$0.89
Miss
Revenue
Estimated$100.00K
ActualN/A
Mar 23, 2026
EPS
Estimated-$0.18
Actual-$0.18
Beat
Revenue
Estimated$100.00K
ActualN/A
Feb 25, 2026
EPS
Estimated-$0.18
Actual-$0.18
Beat
Revenue
Estimated$200.00K
ActualN/A
3 more earnings records available โ€” create a free account to see 12 months of history

Related Activity

Cross-company insider connections and cluster buy signals
Version: v26.3.33